TCG Advisory Services LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

TCG Advisory Services LLC acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,974 shares of the financial services provider’s stock, valued at approximately $268,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Axxcess Wealth Management LLC raised its stake in shares of iShares Biotechnology ETF by 55.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 6,486 shares of the financial services provider’s stock worth $881,000 after purchasing an additional 2,310 shares during the last quarter. First Horizon Advisors Inc. boosted its position in shares of iShares Biotechnology ETF by 5.5% in the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock valued at $298,000 after acquiring an additional 115 shares during the period. Robertson Stephens Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at $204,000. Great Valley Advisor Group Inc. raised its stake in iShares Biotechnology ETF by 14.1% in the fourth quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 344 shares in the last quarter. Finally, Mission Wealth Management LP boosted its holdings in shares of iShares Biotechnology ETF by 20.1% in the 4th quarter. Mission Wealth Management LP now owns 3,022 shares of the financial services provider’s stock worth $410,000 after purchasing an additional 506 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of IBB stock traded down $0.66 during trading hours on Monday, hitting $132.30. 793,469 shares of the company’s stock traded hands, compared to its average volume of 1,788,422. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16. The stock’s fifty day simple moving average is $133.61 and its two-hundred day simple moving average is $130.12.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were paid a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.38%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.